The company now expects to file for full approval by year's end and has a variant-specific shot in advanced testing. But the long-term prospects for AstraZeneca's new vaccine business are unclear.
Original source: https://www.healthcaredive.com/news/astrazeneca-coronavirus-vaccine-us-filing-plans/604153/